Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676858 · ClinicalTrials.gov registry record
Gas Embolism With Use of Argon Plasma Coagulation
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 42
- Enrollment target
NCT00676858: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT00676858 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00676858 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to use transesophageal echocardiography (TEE) to determine the incidence, severity, and clinical significance of gas bubbles during argon plasma coagulation (APC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-07-05 |
What the finished NCT00676858 record still lists
NCT00676858 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00676858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00676858 about?
NCT00676858 is a clinical study titled "Gas Embolism With Use of Argon Plasma Coagulation". The purpose of this study is to use transesophageal echocardiography (TEE) to determine the incidence, severity, and clinical significance of gas bubbles during argon plasma coagulation (APC).
What is the current status of trial NCT00676858?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2008-07. Estimated completion is 2011-07-05.
Who is sponsoring clinical trial NCT00676858?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia